Not recruiting
Chronic obstructive pulmonary disease
Not recruitingStudy on Reducing Antibiotic Use in Severe COPD Exacerbation with Amoxicillin, Cefotaxime, and Ciprofloxacin for Patients on Mechanical Ventilation or Oxygen Therapy
Registered drugNo placebo
Study on Reducing Antibiotic Use in Severe COPD Exacerbation with Amoxicillin, Cefotaxime, and Ciprofloxacin for Patients on Mechanical Ventilation or Oxygen Therapy
Registered drugNo placebo
- Disease:Chronic obstructive pulmonary disease
- Substances:Amoxicillin SodiumCefotaxime+5
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Amoxicillin Sodium
